臨床医が好む治療法を用いたランダム化臨床試験
1Biometric Research Branch, National Cancer Institute, Bethesda, Maryland 20892.
Lancet (London, England)
|January 19, 1991
まとめ
標準的なランダム化臨床試験は,臨床医が特定の治療法を好む状況には適さない場合があります. 代替的なアプローチでは,患者がランダム化されている場合にのみランダム化することを提案しています.
科学分野:
- 臨床試験の方法論 臨床試験の方法論
- 医療倫理 医療倫理について
- 患者中心のケア
背景:
- 標準的なランダム化臨床試験 (RCT) は,臨床医が強い治療好みや優位性についての信念を持っている場合,最適以下である可能性があります.
- 臨床医のバイアスは,従来のRCTにおける試験設計と患者の結果に影響を与える可能性があります.
研究 の 目的:
- 臨床医の治療の好みのある状況のための代替試験設計を提案する.
- 意見の相違がある場合,患者の配分が臨床判断と一致することを保証する.
主な方法:
- 患者のランダムな割り当ては,最良の選択に関する臨床的な意見の相違が生じた場合にのみ推奨されます.
- その後,患者は割り当てられた治療レジメンをサポートする臨床医に割り当てられます.
主要な成果:
- この修正されたアプローチは,臨床医の専門知識または好みにより,標準的なRCTが不適切である可能性のあるシナリオに対応しています.
- 臨床的判断をランダム化プロセスに統合することを目的としています.
結論:
- 提案された設計は,臨床試験の適用性を実用化するための潜在的な解決策を提供します.
- ランダム化と個別化された臨床意思決定のバランスをとろうとしている.
関連する概念動画
Randomized Experiments
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...

